Patients seeking knee treatments in Newport Beach, CA, often want solutions that address the underlying cause of knee discomfort while minimizing surgical intervention. At The Patel Center for Functional Regeneration, care focuses on regenerative medicine approaches designed to support the body’s natural repair processes. Individuals from Orange County, Los Angeles, and surrounding communities frequently explore these options when experiencing symptoms related to ligament strain, cartilage changes, meniscus injury, tendon overuse, or degenerative joint conditions.
Patients often arrive after trying medications, physical therapy, or steroid injections, only to find that relief is temporary or incomplete. Some want to avoid the long recovery and potential complications of knee replacement; others are active athletes who need a safe path back to training without permanent joint damage. Dr. Shounuck Patel offers one of the broadest arrays of non-surgical, advanced cell therapy and platelet procedures available for knee arthritis, meniscus tears, ACL and other ligament and tendon injuries, and overuse injuries.
Knee arthritis is a progressive condition affecting the cartilage, bone, and soft tissues of the joint. As it advances, the protective cartilage that cushions the knee wears down, leading to stiffness, inflammation, and discomfort. According to the CDC, arthritis is a widespread issue in the U.S., and knee osteoarthritis is among the leading causes of disability, particularly in older adults.
Osteoarthritis is often painless in its early stages people can have significant arthritis on imaging with no symptoms at all, while a less-arthritic joint may be the painful one. Pain tends to emerge when a joint with reduced biological health has a harder time recovering from an injury or abnormal loading, becoming irritated and staying that way.
Total knee replacement, while effective for end-stage arthritis, is a major surgical undertaking with a significant recovery period and long-term considerations, including wear particles entering the bloodstream and accelerated joint degeneration over time. Emerging research also indicates that some commonly performed arthroscopic procedures, including meniscus surgery, may provide limited benefit. Research has found that roughly 6 in 10 knee replacement surgeries have no clear medical indication, and about 34% of arthroscopic surgeries are considered inappropriate; approximately 700,000 arthroscopic partial meniscectomies are performed annually in the U.S. at an estimated $4 billion in direct medical costs, despite studies showing the procedure can be no more effective than sham surgery for many patients.
Cortisone injections one of the most common conventional treatments can also work against long-term joint health: research has shown that repeated cortisone injections lead to less cartilage in the knee, temporarily masking pain while speeding the eventual need for surgery.
While surgery remains appropriate for severe or complex cases, regenerative treatment has shown promising results even in challenging situations, including partial and some complete, non-retracted ligament tears. Many patients with advanced arthritis have been able to delay or avoid knee replacement and return to daily activities with minimal pain and little to no downtime.
PRP is the regenerative treatment with the most extensive clinical research in knee conditions. It is prepared from the patient’s own blood through a centrifugation process that concentrates platelets cells that carry growth factors including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and insulin-like growth factor (IGF-1). These growth factors drive tissue repair, modulate inflammation, and stimulate cellular regeneration. Injected under ultrasound guidance directly into damaged tissue, PRP delivers a concentrated regenerative signal to areas with limited native blood supply, such as cartilage and fibrocartilage.
Nearly 50 randomized controlled trials have compared intra-articular PRP to corticosteroids, hyaluronic acid, and placebo. The evidence consistently shows superior pain reduction compared to corticosteroids at six and twelve months, superior pain reduction compared to hyaluronic acid at twelve months in most studies, and measurable functional improvement, with some biochemical and imaging markers suggesting cartilage-protective effects. PRP is not a cure for osteoarthritis and does not regenerate lost cartilage, but it significantly reduces pain and improves function for many patients, often for a year or more.
A typical PRP protocol: 30–60 mL of blood is drawn and processed in a calibrated centrifuge to produce the concentrate; the knee is prepared under sterile conditions; PRP is injected into the joint and/or specific soft tissue areas using real-time ultrasound guidance; the patient is briefly monitored before discharge. Most patients receive a series of one to three injections spaced two to four weeks apart. Some mild swelling in the days following injection is normal, and most patients notice a reduction in pain and inflammation within one to two months.
Cell therapy uses tissue-derived cells from bone marrow or adipose (fat) tissue to create a biologically rich healing environment within the knee joint. This approach can help reduce inflammation and improve joint function, and is particularly useful for patients with moderate to severe arthritis who want to delay or avoid total knee replacement, as well as those with meniscus tears, ligament injuries, or partial and complete non-retracted ACL tears who are hoping to avoid surgery.
Bone Marrow Aspirate Concentrate (BMAC) harvests cells and growth factors from the patient’s own bone marrow (typically the posterior iliac crest, under local anesthesia) and concentrates them for injection into the knee. BMAC contains mesenchymal cells capable of differentiating into various connective tissue types. Evidence is growing for BMAC’s benefit in pain reduction and function, particularly in younger patients with cartilage defects; the procedure is more involved than PRP but may offer greater regenerative potential in the right candidates.
Microfragmented adipose tissue (MFAT) uses a patient’s own fat tissue, processed to remove blood, inflammatory cells, and fatty oils, leaving concentrated adipose components believed to have regenerative properties. MFAT is injected under ultrasound guidance and can target multiple structures around the knee, including soft tissue, meniscus, and tendons, to reduce inflammation and promote healing.
Hyaluronic acid is a naturally occurring molecule in joint fluid that provides lubrication and shock absorption; its concentration and quality decline in osteoarthritic joints. Viscosupplementation injects purified HA directly into the knee to restore lubrication and reduce friction and pain. FDA-approved HA products used for knee arthritis include Synvisc, Euflexxa, Orthovisc, and Hyalgan, with schedules ranging from a single injection to a series over several weeks. Benefits typically last four to six months and can be repeated particularly helpful for patients with mild to moderate disease who aren’t candidates for PRP or who combine HA with PRP.
While the emphasis in regenerative orthopedics is on biologic therapies, corticosteroid injections remain a tool in specific situations significant acute inflammation or effusion that needs to be controlled before starting regenerative treatment, severe arthritis flares causing debilitating pain, or bursitis limiting rehabilitation. Corticosteroids are used judiciously, since frequent use can harm cartilage over time; this is weighed against the need for acute pain control in the moment.
The knee is part of a broader system that includes stabilizing ligaments, surrounding tendons, and the bone beneath the cartilage. In more severe arthritis, the subchondral (intraosseous) bone can become inflamed or structurally weakened. A thorough treatment approach often addresses:
By targeting the full functional unit not just the joint space the goal is to improve the joint’s biology, biomechanics, and stability, not just mask symptoms.
Regenerative injections produce the best outcomes when integrated with targeted physical therapy that supports the biological healing process being stimulated. Dr. Patel collaborates closely with experienced physical therapists in Orange County and integrates movement analysis and biomechanical optimization into care. A well-designed rehabilitation program typically addresses:
The best candidates are patients with mild to moderate knee conditions who have not yet developed end-stage arthritis requiring replacement including partial ligament or meniscus injuries, mild to moderate osteoarthritis, and chronic tendon conditions that haven’t fully responded to physical therapy or other conservative care. Patients hoping to avoid or delay surgery, particularly those with active lifestyles, are often well-suited to these treatments. Regenerative approaches may even offer benefit for more advanced “bone-on-bone” arthritis in select cases, though they are generally less appropriate for patients with significant bone deformity, complete ligament tears requiring surgical reconstruction, or systemic conditions that impair healing.
A thorough evaluation physical examination, review of imaging, and a detailed discussion of goals and medical history allows Dr. Patel to recommend the most appropriate treatment path for each individual.
